Milestone Scientific Inc. (MLSS)
Milestone Scientific Inc. (MLSS) Stock Price, Analysis & Data
No data available
| Bid | n/a |
| Market Cap | 43.38M |
| Revenue (ttm) | 9.42M |
| Net Income (ttm) | -4.14M |
| Beta | n/a |
| EPS (ttm) | -0.05 |
| PE Ratio (ttm) | n/a |
| Forward PE | -13.97 |
| P/B (ttm) | 12.54 |
| P/S (ttm) | 4.61 |
| Earnings Date | Aug 14, 2024 |
| Ask | n/a |
| Volume | 422,177 |
| Avg. Volume (20D) | 189,277 |
| Open | 0.49 |
| Previous Close | 0.50 |
| Day's Range | 0.46 - 0.49 |
| 52-Week Range | 0.22 - 0.65 |
| Analyst | Strong Buy |
| Price Target | 1.25 (155.10%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About MLSS
Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Si...
Financial Performance
In 2025, Milestone Scientific's revenue was 8.97M, an increase of 3.99% compared to the previous year's 8.63M. Earnings were -5.72M, an increase of 21.4%.
Financial StatementsAnalyst Forecast
According to 2 analyst ratings, the average rating for MLSS stock is "Strong Buy". The 12-month stock price forecast is 1.25, which is upside of 155.1% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
